Sam Chun Dang Pharm. Co., Ltd
000250
株式のランク
#4333
Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and... Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and produces a wide variety of medications. Its product range features antibiotics, treatments for cardiovascular and respiratory conditions, drugs for the digestive system and ophthalmic use, as well as anti-inflammatory agents. The company was founded on December 29, 1943, and its main operations are based in Hwaseong-si, South Korea.
株価
$152.58
時価総額
$3.57B
変化（1日）
3.84%
変化（1年）
6.02%
国
KR
取引 Sam Chun Dang Pharm. Co., Ltd (000250)
カテゴリー
Healthcare
Sam Chun Dang Pharm. Co., Ltd（000250）の収益
Jun 2026 時点の収益 TTM: $195.81M
Sam Chun Dang Pharm. Co., Ltd の最新の財務報告によると、現在の収益 (TTM) は $195.81M です。2024 年には $143.47M の収益があり、これは 2023 年の $148.83M と比較して 減少 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Sam Chun Dang Pharm. Co., Ltd の収益履歴（2004 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $195.81M | 22.04% |
| 2025 | $160.45M | 11.83% |
| 2024 | $143.47M | -3.60% |
| 2023 | $148.83M | 5.91% |
| 2022 | $140.53M | -0.12% |
| 2021 | $140.70M | -8.46% |
| 2020 | $153.70M | -4.89% |
| 2019 | $161.60M | 12.49% |
| 2018 | $143.66M | -4.66% |
| 2017 | $150.68M | 23.28% |
| 2016 | $122.23M | 8.77% |
| 2015 | $112.37M | 3.40% |
| 2014 | $108.68M | 9.44% |
| 2013 | $99.30M | 37.91% |
| 2012 | $72.00M | 7.59% |
| 2011 | $66.92M | 0.60% |
| 2010 | $66.52M | 13.64% |
| 2009 | $58.54M | 24.58% |
| 2008 | $46.99M | -21.49% |
| 2007 | $59.85M | 17.07% |
| 2006 | $51.13M | -2.21% |
| 2005 | $52.28M | 3.90% |
| 2004 | $50.32M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $2.54B | 1,195.11% |
US
|
|
| $3.10B | 1,483.21% |
SE
|
|
| $4.54B | 2,220.60% |
FR
|
|
| $3.04B | 1,451.53% |
IT
|
|
| $830.81M | 324.29% |
US
|
